How I Treat Young Adults with Acute Lymphoblastic Leukemia
Description
Upon viewing this session, you will be able to:
• Describe the optimal therapy for AYA patients with ALL
• Discuss the prognostic impact of the Ph-like signature and minimal residual disease (MRD)
• Review novel treatment strategies in the upfront treatment of AYA ALL patients
• Describe the optimal therapy for AYA patients with ALL
• Discuss the prognostic impact of the Ph-like signature and minimal residual disease (MRD)
• Review novel treatment strategies in the upfront treatment of AYA ALL patients
Presenters
- Anjali Advani, MD, Cleveland Clinic
Pricing
| Member Type | Price |
|---|---|
| List Price | $30.00 |
| Active, International, Emeritus, and Honorary Members | $20.00 |
| Associate, International Associate, Student, and Resident Members | $20.00 |
ASH Meeting on Hematologic Malignancies
Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.
Learn more
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2021 by American Society of Hematology